Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Fennec Pharmaceuticals Inc (NQ: FENC )

7.700 USD -0.060 (-0.77%)
Streaming Delayed Price Updated: 1:31 PM EST, Nov 24, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 47,266
Open 7.810
Bid (Size) 7.680 (2)
Ask (Size) 7.750 (26)
Prev. Close 7.760
Today's Range 7.540 - 7.810
52wk Range 4.650 - 10.67
Shares Outstanding 18,578,392
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Fennec Pharmaceuticals Announces Third Quarter 2020 Financial Results and Provides Business Update
From GlobeNewswire News Releases
Processa Pharmaceuticals Announces the Appointment of Dr. Khalid Islam to Its Board of Directors
From GlobeNewswire News Releases

Performance

YTD
+18.83%
+18.83%
1 Month
+4.90%
+4.90%
3 Month
+44.74%
+44.74%
6 Month
+1.58%
+1.58%
1 Year
+32.53%
+32.53%

More News

Read More
FINAL DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Reminds Fennec Pharmaceuticals Inc. Investors of the Important November 2 Deadline in Securities Class Action – FENC
From GlobeNewswire News Releases
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Fennec Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
From GlobeNewswire News Releases
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of FENC, TCMD and TRQ
From ACCESSWIRE
FENC CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files a Securities Fraud Class Action Lawsuit Against Fennec Pharmaceuticals Inc. (FENC)
From PR Newswire
BioMedNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Board Appointment of Dr. Khalid Islam
From InvestorBrandNetwork
FINAL DEADLINE NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Fennec Pharmaceuticals Inc. Investors of the Important November 2 Deadline in Securities Class Action - FENC
From PR Newswire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fennec Pharmaceuticals Inc. (FENC)
From Business Wire News Releases
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fennec Pharmaceuticals Inc. (FENC)
From PR Newswire
DEADLINE ALERT for FENC, POR, HDB, and UPLCQ: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
From GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.